Real-world evidence of patients who received psilocybin through Canada’s Special Access Program
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Secondary analysis of real-world data from Canada's Special Access Program requests for psilocybin from program inception January 2022 to mid March 2026
Fields of Study & Subjects
Psychedelics and Drug Studies
Opioid Use Disorder Treatment
Cannabis and Cannabinoid Research
Publication details
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Preprint